TL;DR: Biobot Analytics does not publish a price list we can verify, which is normal for Government companies at this stage. Below: what we can confirm, how to get a real quote, and 8 comparable tools to benchmark the number against.
What is verifiable about Biobot Analytics pricing, how to get a real quote, and 8 comparable tools to price it against.
Last verified:
Not in any source we can verify. Biobot Analytics is a Y Combinator-backed Government company from the Winter 2018 batch, and companies at this stage usually quote per customer rather than publish rate cards. We will not guess at a number — anything quoted elsewhere without a source is guesswork too. The company profile we work from is the Y Combinator listing; the current figure has to come from Biobot Analytics directly.
These are the closest comparable tools, matched on what Biobot Analytics actually does. Price each one alongside it — stage and team size are a reasonable proxy for where a vendor sits on price.
| Compare against | What it does | Stage | Team |
|---|---|---|---|
| Capveon | Turning infrastructure demand into action | YC Fall 2026 | 2 |
| Blissway | The tolling industry’s prime tech infrastructure | YC Summer 2020 | 22 |
| GovEagle | AI for Government Contractors | YC Winter 2023 | 25 |
| Remix | We’re building a platform to empower cities to plan the best possible… | YC Winter 2015 | 65 |
| Elucd | Polling through mobile ads to enable governments to make better… | YC Summer 2017 | 8 |
| Promise | Better payment systems for governments and the communities they serve. | YC Winter 2018 | 80 |
| XTraffic | Technology for cities to automate and manage their traffic lights. | YC Summer 2024 | 3 |
| DemocracyOS | Online space for deliberation, policy making and democratic… | YC Winter 2015 | 1 |
That depends on a number we cannot see, so judge it on what we can: Biobot Analytics is currently Active with a team of around 12. A small team means faster support and more negotiating room, but more risk of the product changing direction. A larger or public vendor costs more and moves slower. If price is the deciding factor, the earlier-batch companies in the table are usually the ones still competing on it.
See all Biobot Analytics alternatives compared →
Built by LemStudio
Loading interactive view…